UAE to introduce device to combat type II diabetes
Dr. Amin Al Amiri: The UAE's constant efforts to provide the latest innovations to the community has positioned itself as a leading country with premier health care services
By: Orient Planet PR & Marketing Communications
MOHAP has been coordinating with one of the largest French international companies, for the UAE to be the first country in the world to provide the latest medicines for the treatment of type II diabetes, once approved by the FDA, in January next year as expected.
The new medicine is a small device made of titanium in the size of matchmaker and is placed under the skin and under the chest for both men and women. It contains a micro pump that injects the daily dose necessary for the patient with type II diabetes regularly and lasts up to six months, and is expected to reach up to a period of 12 months in mid-2018. This drug is from a group GLP-1 RA in the body, which in turn urges the pancreas to pump insulin. The first drug of this group is not given by injection or pills.
Scientific research and global studies have proven the effectiveness of this drug in reducing blood sugar in addition to weight loss. Thus, this medicine will help type II diabetic patients to adhere to the daily therapeutic dose, which will help in controlling blood sugar levels and avoid complications caused by the disease.
Orient Planet PR & Marketing Communications